Directorate Change - Appointment of CFO

Commercially focused MBA-qualified finance professional brings 20+ years of relevant experience to the Group

Surgical Innovations Group Plc (AIM: SUN), the designer, manufacturer and distributor of innovative technology for minimally invasive surgery, announces the appointment of Chris Martin as Chief Financial Officer ("CFO") and an Executive Director of the Board, effective Monday 10 June 2024. Chris takes over from Interim Financial Consultant, Michael Roper, who will stay on to provide a handover and facilitate a smooth transition.

Chris brings with him over 20 years' experience as a Finance Director in various manufacturing organisations. His most recent role was with Weir Plc, where he served as Regional Finance Director for Europe, North Africa, and Central Asia for six years. Prior to this, from 2004, Chris held Finance Director positions with Jeld-Wen UK, Laing O'Rourke, The Latium Group, and Lafarge S.A.. He obtained an MBA in 2014 and began his finance career in Lafarge Roofing Ltd (part of Lafarge S.A, formerly Redland Plc) in 1990.

CEO, David Marsh, commented: "Chris brings a wealth of experience in growing and improving business performance, managing change, implementing new systems, and developing high-performing teams. We are confident that his expertise and leadership will be valuable to Surgical Innovations as we continue to drive our strategic initiatives forward.

"We would also like to take this opportunity to thank Michael Roper, our Interim Financial Consultant, for his guidance and advice over the past few months."

The following details are disclosed pursuant to Schedule Two Paragraph (g) of the AIM Rules for Companies:

Christopher ("Chris") Jonathan Martin, age 55, holds or has held the following directorships in the past five years:

Current Directorships

None

Directorships held within the last five years

Weir Mineral Europe Limited

There are no further disclosures required to be made in relation to AIM Rule 17.